These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11474745)

  • 1. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type B (Myobloc): pharmacology and biochemistry.
    Callaway JE
    Clin Dermatol; 2004; 22(1):23-8. PubMed ID: 15158541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemistry of botulinum toxin type B.
    Setler P
    Neurology; 2000; 55(12 Suppl 5):S22-8. PubMed ID: 11188981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of botulinum toxin.
    Huang W; Foster JA; Rogachefsky AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):249-59. PubMed ID: 10906647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
    Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
    Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y
    Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxins in neurological disease.
    Comella CL; Pullman SL
    Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeomin: an innovative new botulinum toxin type A.
    Frevert J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC; Thesleff S; Dasgupta BR
    Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.
    Aoki KR; Guyer B
    Eur J Neurol; 2001 Nov; 8 Suppl 5():21-9. PubMed ID: 11851731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of botulinum neurotoxin serotype A.
    Wenzel RG
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure and mode of action of different botulinum toxins.
    Dolly JO; Aoki KR
    Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.